Systagenix Wound Management, formerly the Professional Wound Care Business of Ethicon Inc., a Johnson & Johnson company, will start to operate their own Global Distribution Network when moving away from the transition services being provided by Johnson & Johnson. The creation of a best-in-class distribution network is a important objective for Systagenix towards its goal of becoming the strongest and most admired wound care company in the world. With an internationally renowned advanced and general wound care product portfolio, customers also expect to receive a high level of service from Systagenix.

European distribution network

With around 700 employees worldwide and a production facility in Gargrave, North Yorkshire, UK, Systagenix products are sold in more than a hundred countries. DB Schenker will support Systagenix and will execute their European logistics activities, including the final deliveries to their European customers, from the Gargrave facility as well as from Girona (Northern Spain) and Prague (Czech Republic). Girona and Prague will serve as regional distribution centers for Southern Europe and Central Europe respectively, where the other European customers will be served directly from Gargrave.

DB Schenker was selected from a larger number of Third Party Logistics Companies for their high quality of service and ability to handle the medical products appropriately. Further, the ability to offer a consistent, all-inclusive and cost-effective European approach, covering groupage and full load transportation, regional Fulfilment Centres and parcel deliveries across the whole of Europe, was an important reason of being awarded with this three-year contract.

Cost-effective and timely delivery

Through this concept, Systagenix can commit to deliver customer orders across Europe within 48 hours after placement of the order. The regional fulfilment centres will be replenished from Gargrave on a weekly basis and under central inventory management to ensure the overall European inventories are well balanced and kept to a minimum. The transportation between these sites will be executed by DB Schenker as well."Our innovative and clinically proven products improve peoples lives and can help reduce health care costs." said Mark Kirkup, Systagenix Vice President, Operations, "Through this partnership, with DB Schenker, we will be able to ensure they get to health care professionals across Europe in a timely and cost effective way."